Juehan Wang

Juehan Wang

Auto-generated profile, based on publicly available information

Juehan Wang

West China Hospital of Sichuan University, Chengdu, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2021 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
CZCe Zhu
Ce Zhu
QWQiang Wu
Qiang Wu
BXBing Xiao
Bing Xiao
JWJuehan Wang
Juehan Wang
CLChao Luo
Chao Luo
YSYueming Song
Yueming Song
Background: Patient compliance is essential to the effectiveness of brace treatment for adolescent idiopathic scoliosis (AIS) patients. Subjective measurements like questionnaires and inquiries proved to be arguably inaccurate. Although some scholars have applied temperature/force monitors to measuring patient compliance objectively, few studies to date could monitor patient compliance in real time. The objective of this study is to describe and evaluate a compliance real-time monitoring system of the brace usage in AIS patients.Methods: A compliance real-time monitoring system (specifically consisting of a compliance monitor, a WeChat Mini Program, a cloud-based storage system and a website backstage management system) was designed to manage the brace treatment. Thirty patients receiving brace treatment were enrolled. They were told to upload the data at least once a day. Clinicians downloaded the compliance data and communicated with the patients online based on their analysis of data at least once every 3 months. The measured force, quality compliance (measured force / baseline force), measured time, and quantity compliance (measured time/ prescribed time) were used to evaluate patient compliance. Patients were also asked to rate their satisfaction at the final follow-up.Results: Twenty-eight patients were included in the final analysis. The mean baseline force was 1.23 ± 0.28 N. The mean measured force was 0.79 ± 0.29 N. The mean quality compliance was 64.8 ± 22.2%. The prescribed time of all patients was 23 h. The mean measured time was 14.1 ± 2.9 h. The mean quantity compliance was 61.3 ± 12.6%. Both the quality and quantity compliance during the first 3 months of treatment was significantly lower than the latter 3 months. In this study, 96.4% (27/28) patients were satisfied with the use of the monitoring system, among whom 21.4% (6/28) are very satisfied and 75.0% (21/28) are somewhat satisfied.Conclusions: The compliance real-time monitoring system, without evaluating the clinical and radiographic outcomes for now, has already shown some feasibility and effectiveness for the management of the brace usage in AIS patients. This system, as a useful tool for online patient management and patient-clinician communication, would be potentially employed on a large scale in future for clinicians to improve the compliance and satisfaction of AIS patients who have received brace treatment.

26 March 2020 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
JWJuehan Wang
Juehan Wang
BZBangjian Zhou
Bangjian Zhou
XYXi Yang
Xi Yang
CZChunguang Zhou
Chunguang Zhou
TLTingxian Ling
Tingxian Ling
LLLi-Min Liu
Li-Min Liu

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JWJuehan Wang
Juehan Wang
LHLeizhen Huang
Leizhen Huang
XYXi Yang
Xi Yang
CZCe Zhu
Ce Zhu
YHYong Huang
Yong Huang
YSYueming Song
Yueming Song
Aims. Accumulating evidence reported that the microRNA (miRNA) took an important role in intervertebral disc degeneration (IDD). In this study, we revealed a novel miRNA regulatory mechanism in IDD. Main Methods. The miRNA microarray analyses of human degenerated and normal disc samples were employed to screen out the target miRNA. In vitro and in vivo experiments were conducted to verify the regulatory effect of miR‐101‐3p. Key Findings. The expression level of miR‐101‐3p was significantly decreased in the degenerated disc samples which were confirmed by qRT‐PCR. Moreover, the miR‐101‐3p expression level was changed dynamically according to the disc degeneration grade. Upregulation of miR‐101‐3p expression level inhibited cell apoptosis. Furthermore, stanniocalcin‐1 (STC1) was selected to be the target gene of miR‐101‐3p according to the bioinformatic algorithms. Mechanically, upregulation of miR‐101‐3p significantly decreased the expression of STC1, vascular endothelial growth factor (VEGF), and MAPK pathway expression levels. Therapeutically, in vivo experiment on IDD rat model illustrated that agomir‐101‐3p could effectively suspend IDD. Significance. Our findings demonstrated that miR‐101‐3p alleviated IDD process through the STC1/VEGF/MAPK pathway.